✦ LIBER ✦

Robert F. Keating, James Tait Goodrich, Roger J. Packer: Tumors of the Pediatric Central Nervous System

✍ Scribed by D., Voth

Book ID: 113057499
Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 11 KB
Volume: 25
Category: Article
ISSN: 0344-5607
DOI: 10.1007/s10143-001-0194-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumors of the pediatric central nervous

Tumors of the pediatric central nervous system: edited by Robert F. Keating, James T. Goodrich, and Roger Packer, 560 pages. $199.00, New York: Thieme, 2001, ISBN 0-86577-848-5, rating: ★★★★, recommended audience: neurosurgeons, neurologists, pediatricians, radiologists

✍ Yoon S Hahn 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Gene expression profiling to analyze emb

Gene expression profiling to analyze embryonal tumors of the central nervous system

✍ Roger J. Packer 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 124 KB

Phase II evaluation of topotecan for ped

Phase II evaluation of topotecan for pediatric central nervous system tumors

✍ Susan M. Blaney; Peter C. Phillips; Roger J. Packer; Richard L. Heideman; Stacey 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 2 views

## BACKGROUND. Topotecan is a topoisomerase I inhibitor that has good penetration across the blood-brain barrier and significant antitumor activity against human brain tumor xenografts. In a Phase I trial in children with refractory cancer, topotecan was well tolerated when administered as a 24-ho

Isochromosome 17q in primitive neuroecto

Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system

✍ Dr. Jaclyn A. Biegel; Lucy B. Rorke; Roger J. Packer; Leslie N. Sutton; Luis Sch 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

Magnetic resonance imaging in the evalua

Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage

✍ Roger J. Packer; Robert A. Zimmerman; Larissa T. Bilaniuk 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Neurologic and neuropsychologic treatment related sequelae are increasingly encountered in children with cancer, but conventional means of neurologic investigation are insensitive to the presence and extent of damage. Magnetic resonance imaging (MRI) has shown brain damage not demonstrable by other

Topotecan for the Treatment of Recurrent

Topotecan for the Treatment of Recurrent or Progressive Central Nervous System Tumors – A Pediatric Oncology Group Phase II Study

✍ Richard P. Kadota; Clinton F. Stewart; Marianna Horn; John F. Kuttesch; Peter C. 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 31 KB